Clinical Trials Browser

Phase 2 × Thalidomide × 90 days × Clear all

NCT00869232 2026-05-22

UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission

Phase 2 Active not recruiting

Multiple Myeloma

NCT00871013 2026-05-11

Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy

Phase 2 Active not recruiting

Neoplasms, Plasma Cell